Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of Experts

Mauricette Michallet1, Mohamad Sobh1, Gilbert Deray2

  • 1Hematology Department, Centre de lutte contre le cancer Léon Bérard, Lyon, France.

Insights

This practical guide synthesizes international recommendations for antifungal agents in hematology patients. It offers expert advice on dosing, monitoring, and managing side effects, optimizing antifungal use and patient safety.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Pharmacology

Background:

  • Hematology patients often require antifungal therapy due to increased infection risk.
  • Existing recommendations for antifungal use in this population are fragmented.
  • Managing antifungal agents requires careful consideration of organ function and drug interactions.

Purpose of the Study:

  • To consolidate international guidelines on antifungal agents for hematology patients.
  • To provide expert recommendations on optimizing antifungal therapy, including dose adjustments and side effect management.
  • To create a practical resource for prescribers to ensure safe and effective antifungal use.

Main Methods:

  • Development of a practical guide by a working group of experts.
  • Synthesis of recommendations from international groups on antifungal agents.
  • Inclusion of expert input from nephrology, hepatology, and drug interaction specialists.

Main Results:

  • A comprehensive guide summarizing antifungal recommendations for hematology patients.
  • Detailed advice on dose adjustments, monitoring, and managing side effects of antifungals.
  • Consideration of toxicity and drug interactions tailored to specific indications.

Conclusions:

  • The guide facilitates optimal and safer use of antifungal agents in hematology patients.
  • Prescribers have a consolidated resource for evidence-based antifungal therapy.
  • Improved patient outcomes are expected through informed antifungal management.

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
127
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
126
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
173
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
2.8K
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
190